{ "version": "https://jsonfeed.org/version/1.1", "title": "lite.news — Licensed Health & Biotech News Feed", "description": "Clear, factual global reporting delivered via a licensed news feed and wire service for publishers and platforms. This RSS feed provides a limited sample; full content feeds and reuse rights are available under licence.", "home_page_url": "https://litenews.litegroup.media/", "feed_url": "https://litenews.litegroup.media/feed/health-and-biotech.json", "language": "en", "copyright": "© 2026 NXT Ltd. Content reuse subject to licence. See litegroup.media/reuse-and-licensing/.", "items": [ { "id": "https://lite.news/fda-approves-abbott-s-paraclose-heart-valve-leak-device/", "url": "https://litenews.litegroup.media/fda-approves-abbott-s-paraclose-heart-valve-leak-device/", "title": "FDA Approves Abbott’s Paraclose Heart-Valve Leak Device", "summary": "Paravalvular leaks let blood pass between a replacement valve and surrounding tissue; Paraclose is delivered by catheter to close the opening.", "date_published": "2026-10-29T07:09:34+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-approves-talzenna-combination-for-new-prostate-cancer-use/", "url": "https://litenews.litegroup.media/fda-approves-talzenna-combination-for-new-prostate-cancer-use/", "title": "FDA Approves Talzenna Combination for New Prostate Cancer Use", "summary": "The indication is for HRR-mutated metastatic disease; patients need an FDA-authorized test to identify qualifying mutations.", "date_published": "2026-10-27T08:24:34+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/pascal-gets-us-approval-china-authorizes-asundexian/", "url": "https://litenews.litegroup.media/pascal-gets-us-approval-china-authorizes-asundexian/", "title": "PASCAL Gets US Approval; China Authorizes Asundexian", "summary": "The PASCAL indication covers eligible patients with severe, symptomatic tricuspid regurgitation despite optimal medical treatment.", "date_published": "2026-10-27T07:05:42+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/kelun-reports-interim-sac-tmt-lung-cancer-trial-results/", "url": "https://litenews.litegroup.media/kelun-reports-interim-sac-tmt-lung-cancer-trial-results/", "title": "Kelun Reports Interim Sac-TMT Lung Cancer Trial Results", "summary": "The phase 3 trial enrolled 455 patients in China with advanced nonsquamous lung cancer and PD-L1 scores below 1%.", "date_published": "2026-10-26T10:25:04+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/astrazeneca-reports-survival-gain-misses-pfs-endpoint/", "url": "https://litenews.litegroup.media/astrazeneca-reports-survival-gain-misses-pfs-endpoint/", "title": "AstraZeneca Reports Survival Gain, Misses PFS Endpoint", "summary": "The global Phase III trial enrolled 594 patients with previously treated, CLDN18.2-positive gastric or related cancers.", "date_published": "2026-10-26T08:24:45+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/genmab-and-incyte-plan-colorectal-cancer-combination-trial/", "url": "https://litenews.litegroup.media/genmab-and-incyte-plan-colorectal-cancer-combination-trial/", "title": "Genmab and Incyte Plan Colorectal Cancer Combination Trial", "summary": "Genmab will conduct the proposed trial, and Incyte plans to share its funding and provide INCB161734.", "date_published": "2026-10-25T10:20:14+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/gdfather-neo-reports-bladder-cancer-response-findings/", "url": "https://litenews.litegroup.media/gdfather-neo-reports-bladder-cancer-response-findings/", "title": "GDFATHER-NEO Reports Bladder Cancer Response Findings", "summary": "The phase 2a study enrolled 31 patients who could not receive or declined cisplatin-based chemotherapy.", "date_published": "2026-10-25T07:00:08+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/camupepimut-trial-does-not-meet-primary-endpoint/", "url": "https://litenews.litegroup.media/camupepimut-trial-does-not-meet-primary-endpoint/", "title": "Camupepimut Trial Does Not Meet Primary Endpoint", "summary": "The phase 2 study enrolled 144 patients with resected pancreatic cancer and compared camupepimut with observation.", "date_published": "2026-10-24T06:55:48+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/fda-approves-orladeyo-pellets-for-patients-12-and-older/", "url": "https://litenews.litegroup.media/fda-approves-orladeyo-pellets-for-patients-12-and-older/", "title": "FDA Approves ORLADEYO Pellets for Patients 12 and Older", "summary": "The once-daily pellets are for prevention, not treatment of an acute hereditary angioedema attack.", "date_published": "2026-10-22T18:41:46+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-alert-covers-cardinal-health-presource-kits/", "url": "https://litenews.litegroup.media/fda-alert-covers-cardinal-health-presource-kits/", "title": "FDA Alert Covers Cardinal Health Presource Kits", "summary": "The FDA recommends quarantining affected procedure kits and removing recalled infusion sets; its October 20 alert says details remain under review.", "date_published": "2026-10-21T02:28:51+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-classifies-philips-lumify-correction-as-class-i-recall/", "url": "https://litenews.litegroup.media/fda-classifies-philips-lumify-correction-as-class-i-recall/", "title": "FDA Classifies Philips Lumify Correction as Class I Recall", "summary": "The Lumify ultrasound system has been classified as a Class I recall, according to the regulator. Registration changes are now underway.", "date_published": "2026-10-20T06:39:13+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/mhra-consults-on-adrenaline-nasal-sprays-in-schools/", "url": "https://litenews.litegroup.media/mhra-consults-on-adrenaline-nasal-sprays-in-schools/", "title": "MHRA Consults on Adrenaline Nasal Sprays in Schools", "summary": "A consultation outlines plans for schools to stock spare adrenaline nasal sprays for emergencies, according to the regulator. Access may change soon.", "date_published": "2026-10-19T09:19:23+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-kingdom", "region_label": "United Kingdom" }, { "id": "https://lite.news/space-liintech-s-bee-pc2-module-launched-to-iss-on-spacex-crs-35/", "url": "https://litenews.litegroup.media/space-liintech-s-bee-pc2-module-launched-to-iss-on-spacex-crs-35/", "title": "Space LiinTech’s BEE-PC2 Module Launched to ISS on SpaceX CRS-35", "summary": "The experiment module launched on October 13, 2026, aboard SpaceX CRS-35 to investigate drug molecule binding in microgravity, according to reports.", "date_published": "2026-10-14T18:28:31+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/mhra-sets-out-strategy-2030-to-modernise-uk-medicines-regulation/", "url": "https://litenews.litegroup.media/mhra-sets-out-strategy-2030-to-modernise-uk-medicines-regulation/", "title": "MHRA Sets Out Strategy 2030 to Modernise UK Medicines Regulation", "summary": "A strategy for modernizing UK medicines regulation by 2030 was published on 14 October 2026, according to the regulator's statement.", "date_published": "2026-10-14T14:28:22+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-kingdom", "region_label": "United Kingdom" }, { "id": "https://lite.news/viiv-healthcare-names-axmed-as-distributor-for-hiv-medicines-in-over-50-countries/", "url": "https://litenews.litegroup.media/viiv-healthcare-names-axmed-as-distributor-for-hiv-medicines-in-over-50-countries/", "title": "ViiV Healthcare Names Axmed as Distributor for HIV Medicines in Over 50 Countries", "summary": "An agreement was announced on October 12, 2026, appointing Axmed as a distributor for HIV medicines in over 50 countries, according to reports.", "date_published": "2026-10-12T20:43:08+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/fda-approves-hovilpri-for-drug-resistant-hsv-lesions-in-immunocompromised-adults/", "url": "https://litenews.litegroup.media/fda-approves-hovilpri-for-drug-resistant-hsv-lesions-in-immunocompromised-adults/", "title": "FDA Approves Hovilpri for Drug-Resistant HSV Lesions in Immunocompromised Adults", "summary": "A recent approval details Hovilpri's use for treating drug-resistant HSV lesions in immunocompromised adults, according to the regulator.", "date_published": "2026-10-12T11:22:45+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/kenya-suspends-public-health-staff-hotel-meetings-after-imported-ebola-case/", "url": "https://litenews.litegroup.media/kenya-suspends-public-health-staff-hotel-meetings-after-imported-ebola-case/", "title": "Kenya Suspends Public Health Staff Hotel Meetings After Imported Ebola Case", "summary": "A statement confirms the first imported Ebola case in Kenya on October 6, 2026. Meetings for public health staff were suspended, according to reports.", "date_published": "2026-10-10T18:13:11+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/uk-adds-patient-reported-outcomes-resources-to-digital-mental-health-collection/", "url": "https://litenews.litegroup.media/uk-adds-patient-reported-outcomes-resources-to-digital-mental-health-collection/", "title": "UK Adds Patient-Reported Outcomes Resources to Digital Mental Health Collection", "summary": "New resources for patient-reported outcomes were added to the digital mental health collection on October 8, 2026, according to reports.", "date_published": "2026-10-09T20:26:51+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-kingdom", "region_label": "United Kingdom" }, { "id": "https://lite.news/mhra-expands-guidance-and-initiatives-on-real-world-evidence/", "url": "https://litenews.litegroup.media/mhra-expands-guidance-and-initiatives-on-real-world-evidence/", "title": "MHRA Expands Guidance and Initiatives on Real-World Evidence", "summary": "The MHRA launched a Real-World Evidence guidance hub on October 9, 2026, to support regulatory decisions using real-world data, according to reports.", "date_published": "2026-10-09T18:01:47+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-kingdom", "region_label": "United Kingdom" }, { "id": "https://lite.news/fda-approves-tukysa-combination-for-her2-positive-breast-cancer/", "url": "https://litenews.litegroup.media/fda-approves-tukysa-combination-for-her2-positive-breast-cancer/", "title": "FDA Approves Tukysa Combination for HER2-Positive Breast Cancer", "summary": "The FDA approved Tukysa in combination with trastuzumab and pertuzumab for advanced HER2-positive breast cancer, according to Pfizer.", "date_published": "2026-10-08T17:49:36+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/kenya-reports-first-imported-case-of-bundibugyo-ebola/", "url": "https://litenews.litegroup.media/kenya-reports-first-imported-case-of-bundibugyo-ebola/", "title": "Kenya Reports First Imported Case of Bundibugyo Ebola", "summary": "A traveler from the Democratic Republic of Congo tested positive for Bundibugyo Ebola on October 3, 2026, according to health officials.", "date_published": "2026-10-07T15:55:32+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "global", "region_label": "Global" }, { "id": "https://lite.news/fda-approves-jaypirca-for-previously-untreated-cll-and-sll/", "url": "https://litenews.litegroup.media/fda-approves-jaypirca-for-previously-untreated-cll-and-sll/", "title": "FDA Approves Jaypirca for Previously Untreated CLL and SLL", "summary": "The FDA approved Jaypirca for adults with untreated CLL or SLL without 17p deletion, marking it as the first non-covalent BTK inhibitor.", "date_published": "2026-10-03T05:10:09+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-accepts-roche-s-fenebrutinib-application-for-multiple-sclerosis/", "url": "https://litenews.litegroup.media/fda-accepts-roche-s-fenebrutinib-application-for-multiple-sclerosis/", "title": "FDA Accepts Roche’s Fenebrutinib Application for Multiple Sclerosis", "summary": "A filing describes Roche’s NDA acceptance for fenebrutinib on September 30, 2026, according to the regulator. Priority review status was granted.", "date_published": "2026-10-01T00:00:39+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-approves-abbvie-s-juvmo-for-parkinson-s-disease-treatment/", "url": "https://litenews.litegroup.media/fda-approves-abbvie-s-juvmo-for-parkinson-s-disease-treatment/", "title": "FDA Approves AbbVie’s Juvmo for Parkinson’s Disease Treatment", "summary": "A filing describes the approval of a new treatment for Parkinson's disease, according to the regulator. The decision was made on September 25, 2026.", "date_published": "2026-09-28T14:03:36+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-approves-pasatru-for-adults-with-fibrodysplasia-ossificans-progressiva/", "url": "https://litenews.litegroup.media/fda-approves-pasatru-for-adults-with-fibrodysplasia-ossificans-progressiva/", "title": "FDA Approves Pasatru for Adults With Fibrodysplasia Ossificans Progressiva", "summary": "The FDA has approved Pasatru for treating heterotopic ossification lesions in adults with fibrodysplasia ossificans progressiva, according to the regulator.", "date_published": "2026-09-25T20:29:31+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/galleri-multi-cancer-blood-test-gains-fda-panel-support/", "url": "https://litenews.litegroup.media/galleri-multi-cancer-blood-test-gains-fda-panel-support/", "title": "Galleri Multi-Cancer Blood Test Gains FDA Panel Support", "summary": "A panel voted 10-0 to endorse the Galleri test for detecting multiple cancers through a single blood sample, according to the regulator.", "date_published": "2026-09-24T03:18:17+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-approves-lyrfigtu-for-advanced-cholangiocarcinoma/", "url": "https://litenews.litegroup.media/fda-approves-lyrfigtu-for-advanced-cholangiocarcinoma/", "title": "FDA Approves Lyrfigtu for Advanced Cholangiocarcinoma", "summary": "The FDA approved Lyrfigtu for advanced cholangiocarcinoma on September 23, 2026, targeting FGFR2-altered cases in adults, according to reports.", "date_published": "2026-09-24T03:13:01+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/harassment-of-public-health-leaders-documented-in-post-pandemic-studies/", "url": "https://litenews.litegroup.media/harassment-of-public-health-leaders-documented-in-post-pandemic-studies/", "title": "Harassment of Public Health Leaders Documented in Post-Pandemic Studies", "summary": "A study found 76% of public health leaders reported harassment post-pandemic. Female officials faced higher rates, according to researchers.", "date_published": "2026-09-23T05:45:07+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-workshop-explores-testosterone-use-in-menopausal-women/", "url": "https://litenews.litegroup.media/fda-workshop-explores-testosterone-use-in-menopausal-women/", "title": "FDA Workshop Explores Testosterone Use in Menopausal Women", "summary": "A workshop on testosterone therapy for menopausal women occurred on September 17, 2026. Public input was invited, according to the regulator.", "date_published": "2026-09-23T02:44:13+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/umass-boston-and-boston-sphere-launch-high-school-public-health-initiative/", "url": "https://litenews.litegroup.media/umass-boston-and-boston-sphere-launch-high-school-public-health-initiative/", "title": "UMass Boston and Boston SPHERE Launch High School Public Health Initiative", "summary": "UMass Boston seniors will teach public health topics in three high schools this fall, marking the first project of the Boston SPHERE coalition.", "date_published": "2026-09-22T05:24:36+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/fda-approves-moderna-s-mflusiva-mrna-flu-vaccine-for-adults-50/", "url": "https://litenews.litegroup.media/fda-approves-moderna-s-mflusiva-mrna-flu-vaccine-for-adults-50/", "title": "FDA Approves Moderna’s mFlusiva mRNA Flu Vaccine for Adults 50+", "summary": "A filing describes the FDA's approval of Moderna’s mFlusiva flu vaccine for adults 50 and older, according to reports. Distribution includes CVS.", "date_published": "2026-09-21T04:21:37+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/amneal-launches-fda-approved-generic-lanreotide-injection/", "url": "https://litenews.litegroup.media/amneal-launches-fda-approved-generic-lanreotide-injection/", "title": "Amneal Launches FDA-Approved Generic Lanreotide Injection", "summary": "FDA approved Amneal's lanreotide injection on September 18, 2026. The product launched commercially the same day, according to reports.", "date_published": "2026-09-20T01:29:05+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" }, { "id": "https://lite.news/robert-f-kennedy-jr-addresses-vaccine-policy-at-health-conference/", "url": "https://litenews.litegroup.media/robert-f-kennedy-jr-addresses-vaccine-policy-at-health-conference/", "title": "Robert F. Kennedy Jr. Addresses Vaccine Policy at Health Conference", "summary": "A health conference featured discussions on vaccine policy, addressing federal actions amid rising measles cases, according to reports.", "date_published": "2026-09-19T04:19:17+00:00", "tags": [ "health-and-biotech" ], "tags_label": [ "Health & Biotech" ], "region": "united-states", "region_label": "United States" } ], "icon": "https://litenews.litegroup.media/assets/og-default.jpg" }